{
    "nct_id": "NCT03207724",
    "official_title": "A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia",
    "inclusion_criteria": "* Advanced or locally advanced pancreatic cancer patients (can include new or recurrent diagnosis) referred to SOCCI-CSMC for chemotherapy that has progressed through or intolerant to gemcitabine based chemotherapy\n* Cachexia defined as greater than 5% unexplained weight loss within any 6 month period prior to screening visit OR as documented by the medical physician based on standard diagnosis of cachexia\n* Age â‰¥ 18 years\n* ECOG performance status 0-2 or Karnofsky PS >60%\n* Patients must have normal organ and marrow function\n* Ability to understand and the willingness to sign a written informed consent\n* Negative pregnancy test for WOCBP\n* WOCBP and men must agree to use of adequate contraception\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who are currently receiving any other investigational agents\n* Patients who have received more than one chemotherapeutic regimen in metastatic setting\n* Patients with CNS metastases\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements\n* Patients with unresolved grade 3/4 adverse effects of prior therapy at time of enrollment\n* Subjects with history of hypersensitivity to compounds of similar chemical or biologic composition to Xilonix or Onivyde\n* Women who are pregnant or breastfeeding\n* Dementia or altered mental status that would prohibit the understanding or rendering of informed consent\n* Patients with known Dihydropyrimidine dehydrogenase deficiency (DPD deficiency)\n* Patients known to be UGT1A1*28 allele homozygous\n* Patients who have had a live vaccine within 3 months of enrollment",
    "miscellaneous_criteria": ""
}